163 related articles for article (PubMed ID: 31144474)
21. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis.
Tarao K; Rino Y; Ohkawa S; Tamai S; Miyakawa K; Takakura H; Endo O; Yoshitsugu M; Watanabe N; Matsuzaki S
Cancer; 2002 Mar; 94(6):1787-95. PubMed ID: 11920542
[TBL] [Abstract][Full Text] [Related]
22. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.
Elsemman IE; Mardinoglu A; Shoaie S; Soliman TH; Nielsen J
Mol Biosyst; 2016 Apr; 12(5):1496-506. PubMed ID: 27040643
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of hepatitis C-associated hepatocellular carcinoma.
Liang TJ; Heller T
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S62-71. PubMed ID: 15508105
[TBL] [Abstract][Full Text] [Related]
24. Roles of long noncoding RNAs in hepatocellular carcinoma.
Shi L; Peng F; Tao Y; Fan X; Li N
Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
26. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
27. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
28. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma.
Caselmann WH; Alt M
J Hepatol; 1996; 24(2 Suppl):61-6. PubMed ID: 8836891
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.
Vescovo T; Refolo G; Vitagliano G; Fimia GM; Piacentini M
Clin Microbiol Infect; 2016 Oct; 22(10):853-861. PubMed ID: 27476823
[TBL] [Abstract][Full Text] [Related]
31. Preneoplastic lesions in chronic hepatitis C.
Thung SN; Hytiroglou P; Fiel I; Theise N
Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
[TBL] [Abstract][Full Text] [Related]
34. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.
Ogata H; Kobayashi T; Chinen T; Takaki H; Sanada T; Minoda Y; Koga K; Takaesu G; Maehara Y; Iida M; Yoshimura A
Gastroenterology; 2006 Jul; 131(1):179-93. PubMed ID: 16831601
[TBL] [Abstract][Full Text] [Related]
35. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
36. c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair.
Machida K; Tsukamoto H; Liu JC; Han YP; Govindarajan S; Lai MM; Akira S; Ou JH
Hepatology; 2010 Aug; 52(2):480-92. PubMed ID: 20683948
[TBL] [Abstract][Full Text] [Related]
37. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
38. Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.
Plissonnier ML; Lahlali T; Michelet M; Lebossé F; Cottarel J; Beer M; Neveu G; Durantel D; Bartosch B; Accardi R; Clément S; Paradisi A; Devouassoux-Shisheboran M; Einav S; Mehlen P; Zoulim F; Parent R
PLoS Biol; 2016 Mar; 14(3):e1002421. PubMed ID: 27031829
[TBL] [Abstract][Full Text] [Related]
39. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
40. HCV-associated hepatocellular carcinoma without cirrhosis.
el-Refaie A; Savage K; Bhattacharya S; Khakoo S; Harrison TJ; el-Batanony M; Soliman el-S ; Nasr S; Mokhtar N; Amer K; Scheuer PJ; Dhillon AP
J Hepatol; 1996 Mar; 24(3):277-85. PubMed ID: 8778193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]